 | of Coronavac. On 4 May, the EMA's human medicines committee (CHMP) started a rolling review of CoronaVac. In June, Bangladesh approved Coronavac for... 120 KB (11,030 words) - 21:48, 14 April 2024 |
 | EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology.... 39 KB (3,883 words) - 03:25, 12 February 2024 |
Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | declared CoronaVac as halal. On 11 January, the National Agency of Drug and Food Control (BPOM) published an emergency use authorization for CoronaVac from... 95 KB (9,305 words) - 21:31, 9 November 2023 |
 | "HEALTH DEPARTMENT WELCOME THE APPROVAL OF CORONAVAC COVID- 19 VACCINE - SA Corona Virus Online Portal". SA Corona Virus Online Portal. 3 July 2021. Retrieved... 159 KB (11,635 words) - 14:00, 13 February 2024 |
| SARS-CoV-2 Beta variant (section CoronaVac) antibody response was about 6.1 times less against the beta variant. CoronaVac is yet to be approved for use by the South African Health Products Authority... 72 KB (6,070 words) - 06:39, 3 February 2024 |
 | deaths. The Instituto Butantan imported the first 6 million doses of CoronaVac in a collaboration with the Chinese company Sinovac Biotech. There is... 87 KB (8,026 words) - 18:26, 9 February 2024 |
 | Sputnik V COVID-19 vaccine (redirect from Gam-COVID-Vac Lyo) than those seen in people vaccinated with the Pfizer-BioNTech vaccine or CoronaVac. On June 4, Anvisa approved exceptional imports of Sputnik V, restricting... 154 KB (13,880 words) - 13:52, 20 April 2024 |
 | que comprova maior eficácia da Coronavac é enviado para Lancet" [Clinical study proving greater efficacy of Coronavac is submitted to The Lancet]. CNN... 19 KB (1,370 words) - 04:48, 12 October 2023 |
 | COVID-19 pandemic (redirect from Corona outbreak) effective against the Beta variant in a clinical trial in South Africa. The CoronaVac vaccine was reported to be 50.4 percent effective in a Brazil clinical... 372 KB (32,326 words) - 08:00, 2 May 2024 |